|
Please join the NIH Office of Behavioral and Social Sciences Research (OBSSR) for a virtual presentation by Jeffrey Olgin, M.D., Gallo-Chatterjee Distinguished Professor of Medicine and Chief of the Cardiology Division at the University of California, San Francisco, on Tuesday, May 14, from 2:00 to 3:00 pm ET. Please feel free to share this information with your colleagues and stakeholders.
Register: https://go.usa.gov/xmgyd
Presentation Overview
This presentation will provide an overview of the Eureka Research Platform, an NIH-funded resource designed to facilitate mobile and internet-based technology research. Dr. Olgin will describe the digital platform (including its participant-facing "front-end," study management portal, and secure "back-end" for data storage and analyses, and a cohort of volunteers interested in contributing to research), provide a description of ongoing studies using the platform, and share lessons learned and the mechanisms by which the resource can be used for investigators conducting medical or health-related research.
Presenter Biography
Dr. Jeffrey Olgin is the principal investigator of the VEST Study, a large, multi-center randomized study investigating ways to prevent sudden cardiac death after a heart attack. Dr. Olgin and his colleagues have also started the Health eHeart Study, an innovative approach of leveraging the internet, mobile and sensor technology to collect massive amounts of data in real-life and real-time to develop better prediction algorithms for heart disease, develop new mobile health technology, and innovate new paradigms for disease management.
He also leads an NIH-funded initiative to create and run a resource for efficiently running clinical studies using mobile and digital technology, called Eureka. His basic research laboratory studies mechanisms of abnormal heart rhythms and strives to understand the mechanisms of the unique changes that occur in the atria of people who eventually develop atrial fibrillation. Dr. Olgin's research attempts to identify molecular pathways that promote these changes to develop therapies that can prevent atrial fibrillation from occurring.
The recording of this webinar will be available with closed captioning on OBSSR's website approximately one month after the event: https://go.usa.gov/xmgyd
For further information, please contact Erica Moore at 301-594-4392 or erica.moore2@nih.gov
| 
No comments:
Post a Comment